SPONSOR

Shanghai Zhongshan Hospital

Total Trials

Recruiting

Phases

Phase 4, Phase 3, Phase 2, EARLY_Phase 1

Conditions studied: Takayasu Arteritis Tocilizumab Adalimumab Treatment Coronary Artery Disease Coronary Artery Disease (Left Main)Obstructive Coronary Artery Disease Stent Implantation Esophageal Squamous Cell Carcinoma Neoadjuvant Chemoimmunotherapy

Shanghai Zhongshan Hospital is a clinical research sponsor with 25 registered studies on ClinicalTrials.gov, of which 25 are actively recruiting participants. Research covers conditions including Takayasu Arteritis, Tocilizumab, Adalimumab, Treatment.

The trial portfolio spans Phase 4, Phase 3, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Shanghai Zhongshan Hospital

How many clinical trials has Shanghai Zhongshan Hospital sponsored?

ClinicalMetric currently tracks 25 clinical trials sponsored by Shanghai Zhongshan Hospital, of which 25 are actively recruiting participants. These trials cover conditions including Takayasu Arteritis, Tocilizumab, Adalimumab. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

What therapeutic areas does Shanghai Zhongshan Hospital research focus on?

Shanghai Zhongshan Hospital clinical trials span Takayasu Arteritis, Tocilizumab, Adalimumab, Treatment, Coronary Artery Disease, and additional conditions. The research pipeline includes Phase 4, Phase 3, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.

How do I participate in a Shanghai Zhongshan Hospital clinical trial?

To participate in a Shanghai Zhongshan Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Shanghai Zhongshan Hospital trials with current recruitment status updated daily.

Shanghai Zhongshan Hospital

Frequently Asked Questions — Shanghai Zhongshan Hospital

Clinical Trials by Shanghai Zhongshan Hospital

A Pilot Study in Severe Patients With Takayasu Arteritis.

µQFR for Branch Stenosis After Single Stent in Bifurcation Lesions

Neoadjuvant Anti-PD-1 Plus Chemotherapy in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma

Efficacy and Safety of Multimodal Ablation Combined With PD-1 Monoclonal Antibody, Lenvatinib and TACE in the Treatment of Unresectable Primary Hepatocellular Carcinoma: A Single-Arm, Single-Center Clinical Study

FreeFlow Percutaneous Atrial Septal Shunt for IPAH

NALIRIFOX Plus Targeted Therapy Versus FOLFOX Plus Targeted Therapy as First-line Treatment for Metastatic Colorectal Cancer

Efficacy and Safety of iGlarLixi Versus Standard of Care in a Real-world Adult China Population With Uncontrolled Type 2 Diabetes on Oral Agents

A Randomized, Controlled, Open-label, Multicenter Clinical Trial Comparing the Efficacy and Safety of a Precision Treatment Regimen Based on Clinical-molecular Phenotypes with a Conventional Treatment Regimen in the Treatment of Patients with Active Takayasu's Arteritis

DCB vs DES for Severe Coronary Calcification After Optimal Modification Assessed by QFR

Multicenter Study on Laparoscopic Total Gastrectomy for Advanced Gastric Cancer

Impact of External Drainage of the Main Pancreatic Duct and Common Bile Duct on Pancreatic Fistula Following Pancreaticoduodenectomy

CHART Study of Coronary CT Angiography in Coronary Artery Disease

A Phase II Study to Evaluate the Efficacy and Safety of Teclistamab in Combination With Daratumumab (Tec-Dara) in Newly Diagnosed Multiple Myeloma With Concurrent Light Chain Amyloidosis (MM+AL).

An Exploratory Clinical Study of HRS-4642 in Combination With Immunotherapy and Chemotherapy for Pancreatic Cancer

Development of an Intraoperative Adaptive Biopsy System for Prostate Cancer: Integrating Imaging Navigation With Metabolic Feedback for Dynamic Decision-Making

A Prospective Observational Study Using the FAM-CAM

Benmelstobart Combined With Radiochemotherapy as Neoadjuvant Treatment Iin ESCC

Asiaticoside for Treating Overweight/Obesity

Improve the Strategies of Endoscopic and Interventional Treatment of Gastroesophageal Hemorrhage in Portal Hypertension

A Randomized Controlled Trial Comparing Clinical Effectiveness of SMILE Versus SMILE Xtra in Myopia

Organ Preservation Strategy of Total Neoadjuvant Chemoradiotherapy for Low Rectal Carcinoma

Allogeneic Anti-CD7 CAR-T for Type 1 Diabetes

Impact of Hyperemic State on Angio-IMR Performance

In Vivo CAR-T for Refractory Graves' Disease

Detection of Peritoneal Metastasis of Gastric Cancer by Liquid Biopsy in Peripheral Blood: A Prospective Study